Revance Therapeutics, Inc is a biotechnology business based in the US. Revance Therapeutics shares (RVNC) are listed on the NASDAQ and all prices are listed in US Dollars. Revance Therapeutics employs 470 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Revance Therapeutics
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – RVNC – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Revance Therapeutics stock price (NASDAQ: RVNC)Use our graph to track the performance of RVNC stocks over time.
Revance Therapeutics shares at a glance
|Latest market close||$29.61|
|52-week range||$22.89 - $33.83|
|50-day moving average||$30.44|
|200-day moving average||$28.55|
|Wall St. target price||$38.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-3.71|
Buy Revance Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Revance Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Revance Therapeutics price performance over time
|1 week (2021-07-16)||N/A|
|1 month (2021-06-25)||-3.93%|
|3 months (2021-04-27)||1.37%|
|6 months (2021-01-23)||N/A|
|1 year (2020-07-23)||N/A|
|2 years (2019-07-23)||N/A|
|3 years (2018-07-23)||N/A|
|5 years (2016-07-23)||N/A|
Revance Therapeutics financials
|Revenue TTM||$28.6 million|
|Gross profit TTM||$-97,211,000|
|Return on assets TTM||-26.32%|
|Return on equity TTM||-105.6%|
|Market capitalisation||$2.2 billion|
TTM: trailing 12 months
Shorting Revance Therapeutics shares
There are currently 3.2 million Revance Therapeutics shares held short by investors – that's known as Revance Therapeutics's "short interest". This figure is 3.6% up from 3.1 million last month.
There are a few different ways that this level of interest in shorting Revance Therapeutics shares can be evaluated.
Revance Therapeutics's "short interest ratio" (SIR)
Revance Therapeutics's "short interest ratio" (SIR) is the quantity of Revance Therapeutics shares currently shorted divided by the average quantity of Revance Therapeutics shares traded daily (recently around 439676.65745856). Revance Therapeutics's SIR currently stands at 7.24. In other words for every 100,000 Revance Therapeutics shares traded daily on the market, roughly 7240 shares are currently held short.
However Revance Therapeutics's short interest can also be evaluated against the total number of Revance Therapeutics shares, or, against the total number of tradable Revance Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Revance Therapeutics's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Revance Therapeutics shares in existence, roughly 40 shares are currently held short) or 0.0485% of the tradable shares (for every 100,000 tradable Revance Therapeutics shares, roughly 49 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Revance Therapeutics.
Find out more about how you can short Revance Therapeutics stock.
Revance Therapeutics share dividends
We're not expecting Revance Therapeutics to pay a dividend over the next 12 months.
Revance Therapeutics share price volatility
Over the last 12 months, Revance Therapeutics's shares have ranged in value from as little as $22.89 up to $33.83. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Revance Therapeutics's is 1.2437. This would suggest that Revance Therapeutics's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Revance Therapeutics overview
Revance Therapeutics, Inc. , a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection (DAXI), which has completed phase III clinical trials for the treatment of glabellar (frown) lines and cervical dystonia; is in phase II clinical trials to treat upper facial lines, moderate or severe dynamic forehead lines, and moderate or severe lateral canthal lines; and has completed Phase II clinical trials for the treatment of adult upper limb spasticity and plantar fasciitis. It is also developing DAXI in preclinical trial for the treatment of migraine, as well as a topical program for various indications; and OnabotulinumtoxinA, a biosimilar to BOTOX. The company has a collaboration and license agreement with Viatris Inc. for the development and regulatory approval of a biosimilar to BOTOX. The company was formerly known as Essentia Biosystems, Inc.
Stocks similar to Revance Therapeutics
Revance Therapeutics in the news
First Week of September 17th Options Trading For Revance Therapeutics (RVNC)
Planning Alternatives Ltd Buys iShares MSCI USA ESG Optimized ETF, iShares MSCI EAFE ESG Select ETF, iShares ESG Aware MSCI USA Small-Cap ETF, Sells Vanguard Total Bond Market ETF, Schwab US Aggregate Bond ETF, iShares Core U.S. Aggregate Bond ETF
How Much Of Revance Therapeutics, Inc. (NASDAQ:RVNC) Do Institutions Own?
Frequently asked questionsWhat percentage of Revance Therapeutics is owned by insiders or institutions?
Currently 2.875% of Revance Therapeutics shares are held by insiders and 90.537% by institutions. How many people work for Revance Therapeutics?
Latest data suggests 470 work at Revance Therapeutics. When does the fiscal year end for Revance Therapeutics?
Revance Therapeutics's fiscal year ends in December. Where is Revance Therapeutics based?
Revance Therapeutics's address is: 1222 Demonbreun Street, Newark, CA, United States, 37203 What is Revance Therapeutics's ISIN number?
Revance Therapeutics's international securities identification number is: US7613301099 What is Revance Therapeutics's CUSIP number?
Revance Therapeutics's Committee on Uniform Securities Identification Procedures number is: 761330109
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy HNC Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert